Cart
sales@molnova.com
Nepafenac
CAS No. 78281-72-8
Nepafenac( AHR-9434 | AL-6515 )
Catalog No. M15955 CAS No. 78281-72-8
A nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | In Stock |
|
| 25MG | 33 | In Stock |
|
| 50MG | 54 | In Stock |
|
| 100MG | 91 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 221 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNepafenac
-
NoteResearch use only, not for human use.
-
Brief DescriptionA nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.
-
DescriptionA nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.Other Indication Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsAHR-9434 | AL-6515
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1|COX-2
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number78281-72-8
-
Formula Weight254.2839
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESO=C(N)CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N
-
Chemical NameBenzeneacetamide, 2-amino-3-benzoyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gamache DA, et al. Inflammation. 2000 Aug;24(4):357-70.
2. Singh RP, et al. Ophthalmology. 2017 Jun;124(6):776-785.
3. Abu Hussein NB, et al .J Ophthalmol. 2017;2017:3765253.
molnova catalog
related products
-
Thonzylamine
Thonzylamine is an antihistamine and anticholinergic drug. It is available as combination products with Clofedanol or Phenylephrine for temporary relief of symptoms of common cold, hay fever (allergic rhinitis) or other upper respiratory allergies.
-
Pelubiprofen
Pelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity.
-
Inulicin
Inulicin, an active compound isolated from Inula Britannica L, inhibits VEGF-mediated activation of Src and FAK.
